Movement Disorders Associated with Infections in Immunocompromised Non-HIV Patients: A Systematic Review
Objective: To identify the most frequent movement disorders and their clinical features, as well as the most common infectious etiologies in immunocompromised non-HIV patients, based…Immunological characteristics of Parkinson’s disease by clinical form and stage
Objective: To analysed of IL-10 concentrations in serum of patients with PD. Background: IL-10 is a key pro-inflammatory cytokine involved in the regulation of microglia…Immunological principles of levodopa therapy in Parkinson’s disease
Objective: Study of the relationship between serum IL-10 levels in patients with Parkinson's disease and levodopa therapy Background: In Parkinson's disease, dehydroepiandrosterone can lead to…Levels of cytokines in the cerebrospinal fluid of patients depending on the stages of Parkinson’s disease
Objective: To study of cytokine levels in serum and cerebrospinal fluid of patients with different stages of PD. Background: The clinical course of Parkinson's disease…Azathioprine-associated changes in peripheral–central immune signalling in Parkinson’s disease: post-hoc analysis of AZA-PD
Objective: To assess whether changes in peripheral markers of CNS immune cell trafficking relate to clinical response to azathioprine in AZA-PD Background: We conducted a…Role and significance of C-reactive protein in stages of Parkinson’s disease
Objective: To сomparative analysis of the amount of CRP in the blood serum of patients according to the stages of PD. Background: C-reactive protein (CRP)…Levels of IgA and IgG concentrations by stage of Parkinson’s disease
Objective: To study of IgA and IgG levels cerebrospinal fluid of patients with different stages of PD. Background: In the clinical course of Parkinson's disease…Early Impairment in the Immunomodulatory Function of Mesenchymal Stromal Cells Contributes to Heightened Peripheral and Neuroinflammation in Parkinson’s Disease Insights From In Vivo Chronic PD Rat Model and In Vitro PD iPSC Model
Objective: To assess the timeline dependent changes in endogenous Bone-Marrow-Mesenchymal-Stromal-Cells (BMMSC) in in-vivo chronic PD model and validating these cellular modifications in human iPSC derived…Parkinsonism Due to Delayed Neurotoxicity of CAR-T Therapy
Objective: We report a case of secondary parkinsonism due to delayed neurotoxicity induced by ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy (CAR-T) as well…Hyperkinetic Movement Disorder associated with Papillary Thyroid Carcinoma
Objective: To describe a case of hyperkinetic movement disorder associated with papillary thyroid carcinoma, highlighting the diagnostic workup and therapeutic interventions. Background: Paraneoplastic neurological syndromes…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.